A pharmacologically pre-contracted smooth muscle bowel model for the study of highly-potent opioid receptor agonists and antagonists.
Dose response relationship
Isolated organ
Opioids
Journal
Toxicology letters
ISSN: 1879-3169
Titre abrégé: Toxicol Lett
Pays: Netherlands
ID NLM: 7709027
Informations de publication
Date de publication:
01 Jun 2023
01 Jun 2023
Historique:
received:
18
07
2022
revised:
24
02
2023
accepted:
22
05
2023
medline:
13
6
2023
pubmed:
29
5
2023
entrez:
28
5
2023
Statut:
ppublish
Résumé
Isolated organ models are a versatile tool for pharmacological and toxicological research. Small bowel has been used to assess the inhibition of smooth muscle contraction by opioids. In the present study, we set out to establish a pharmacologically stimulated rat bowel model. The effects of carfentanil, remifentanil and the new synthetic opioid U-48800 and their respective antagonists naloxone, nalmefene and naltrexone were studied in a small bowel model in rats. The IC
Identifiants
pubmed: 37245850
pii: S0378-4274(23)00187-X
doi: 10.1016/j.toxlet.2023.05.010
pii:
doi:
Substances chimiques
Analgesics, Opioid
0
Naltrexone
5S6W795CQM
Remifentanil
P10582JYYK
Narcotic Antagonists
0
Naloxone
36B82AMQ7N
Receptors, Opioid
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
41-46Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Prof. Dr. Franz Worek is a member of the editorial board of Toxicology Letters. Conflict of interest statement The authors declare that there are no conflicts of interest. The study was funded by the German Ministry of Defence. However, the design, performance, data interpretation and manuscript writing were under the control of the authors and has not been influenced by the German Ministry of Defence.